-
Mayo Clinic Research Information Center Presents ‘Changing Lives Through Research’
Share this:
ROCHESTER, Minn. — On April 27, the Mayo Clinic Research Information Center will present “Changing Lives Through Research,” an informal gathering featuring the Mayo Clinic Center for Individualized Medicine. Here, you can find out more about precision medicine and hear from a variety of speakers on how it is changing people’s lives through research into the field of genome sequencing, the microbiome, pharmacogenomics and more. Drop in for any of the presentations, ask questions and learn more about precision medicine.
Review the program for the “Changing Lives Through Research” gathering.
Wednesday, April 27
Research Information Center, Gonda Lobby
10-10:30 a.m.
“Future of Individualized Medicine”
Scott Beck, associate administrator, Center for Individualized Medicine
11-11:30 a.m.
“Family History and Me”
Teresa Kruisselbrink, M.S., certified genetic counselor
12:30-1:30 p.m.
“Microbiome: Your Body, Your Bugs, Your Health”
Purna Kashyap, M.B.B.S., Gastroenterology and Hepatology
Nicholas Chia, Ph.D., Surgical Research
Marina Walther-Antonio, Ph.D., Surgical Research
1:30-2:30 p.m.
“Medication and My Genes: Why Does It Matter?”
Richard Weinshilboum, M.D., Pharmacology Research
Visit the Mayo Clinic's Research Information Center in the Gonda Lobby on April 27 between 10 a.m. and 1:30 p.m. for the presentations. The Research Information Center is open to the public weekdays from 8 a.m. to 5 p.m.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or https://newsnetwork.mayoclinic.org/.
MEDIA CONTACT: Colette Gallagher, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu
Share this:
Related articles
The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, ...
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of ...
DEAR MAYO CLINIC: My elderly mom has recently been told she needs to take a bunch of different medications every day due to her health ...